Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 61 | 2025 | 695 | 8.550 |
Why?
|
| Tissue Scaffolds | 50 | 2025 | 431 | 7.450 |
Why?
|
| Regeneration | 9 | 2023 | 178 | 2.220 |
Why?
|
| Extracellular Matrix | 13 | 2025 | 255 | 1.920 |
Why?
|
| Muscle, Skeletal | 10 | 2020 | 520 | 1.910 |
Why?
|
| Hydrogels | 14 | 2025 | 125 | 1.900 |
Why?
|
| Collagen | 15 | 2020 | 229 | 1.880 |
Why?
|
| Animals | 66 | 2025 | 8165 | 1.870 |
Why?
|
| Polyesters | 16 | 2019 | 76 | 1.850 |
Why?
|
| Biocompatible Materials | 21 | 2024 | 240 | 1.830 |
Why?
|
| Stem Cells | 11 | 2025 | 317 | 1.610 |
Why?
|
| Bioprosthesis | 4 | 2023 | 60 | 1.440 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2023 | 82 | 1.440 |
Why?
|
| Regenerative Medicine | 5 | 2024 | 216 | 1.360 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2017 | 90 | 1.320 |
Why?
|
| Ear Cartilage | 4 | 2021 | 12 | 1.290 |
Why?
|
| Gelatin | 6 | 2019 | 29 | 1.250 |
Why?
|
| Myoblasts, Skeletal | 2 | 2020 | 21 | 1.210 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 767 | 1.180 |
Why?
|
| Guided Tissue Regeneration | 6 | 2020 | 39 | 1.160 |
Why?
|
| Organoids | 3 | 2025 | 101 | 1.120 |
Why?
|
| Cell Differentiation | 13 | 2025 | 452 | 1.110 |
Why?
|
| Troponin I | 4 | 2021 | 20 | 1.100 |
Why?
|
| Bone and Bones | 3 | 2025 | 91 | 1.050 |
Why?
|
| Materials Testing | 10 | 2018 | 89 | 1.050 |
Why?
|
| Humans | 56 | 2025 | 32284 | 1.000 |
Why?
|
| Drug Delivery Systems | 4 | 2025 | 105 | 0.990 |
Why?
|
| Alginates | 3 | 2023 | 52 | 0.960 |
Why?
|
| Microfluidics | 2 | 2025 | 18 | 0.950 |
Why?
|
| Microscopy, Electron, Scanning | 18 | 2020 | 102 | 0.890 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 106 | 0.880 |
Why?
|
| Cartilage | 1 | 2025 | 33 | 0.880 |
Why?
|
| Postoperative Complications | 2 | 2020 | 818 | 0.860 |
Why?
|
| Amniotic Fluid | 7 | 2019 | 85 | 0.860 |
Why?
|
| Cell Proliferation | 16 | 2020 | 599 | 0.860 |
Why?
|
| Cell Survival | 12 | 2025 | 286 | 0.850 |
Why?
|
| Polyglactin 910 | 2 | 2019 | 6 | 0.850 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 40 | 0.830 |
Why?
|
| Cells, Cultured | 18 | 2019 | 821 | 0.830 |
Why?
|
| Surgical Procedures, Operative | 2 | 2021 | 78 | 0.780 |
Why?
|
| Lactic Acid | 7 | 2014 | 56 | 0.780 |
Why?
|
| Models, Biological | 1 | 2025 | 403 | 0.770 |
Why?
|
| Wound Healing | 6 | 2023 | 180 | 0.770 |
Why?
|
| Polymers | 5 | 2016 | 65 | 0.730 |
Why?
|
| Coronary Artery Bypass | 2 | 2020 | 100 | 0.730 |
Why?
|
| Stem Cell Transplantation | 4 | 2024 | 219 | 0.720 |
Why?
|
| Rats | 14 | 2020 | 1892 | 0.680 |
Why?
|
| Osteogenesis | 8 | 2025 | 79 | 0.680 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 60 | 0.660 |
Why?
|
| Swine | 11 | 2023 | 229 | 0.650 |
Why?
|
| Blood Vessels | 3 | 2010 | 58 | 0.630 |
Why?
|
| Muscular Diseases | 1 | 2020 | 23 | 0.610 |
Why?
|
| Hospital Mortality | 2 | 2020 | 197 | 0.610 |
Why?
|
| Kidney | 4 | 2022 | 520 | 0.610 |
Why?
|
| Ink | 2 | 2019 | 11 | 0.610 |
Why?
|
| Heart Diseases | 1 | 2021 | 114 | 0.610 |
Why?
|
| Nanofibers | 1 | 2019 | 7 | 0.610 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 67 | 0.600 |
Why?
|
| Skin Transplantation | 2 | 2023 | 49 | 0.550 |
Why?
|
| Mice | 22 | 2023 | 2544 | 0.550 |
Why?
|
| Body Mass Index | 1 | 2021 | 863 | 0.530 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2017 | 54 | 0.530 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 28 | 0.530 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 167 | 0.520 |
Why?
|
| Cell Adhesion | 12 | 2012 | 95 | 0.510 |
Why?
|
| Bone Regeneration | 4 | 2020 | 33 | 0.510 |
Why?
|
| Neurons | 2 | 2020 | 484 | 0.510 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2025 | 29 | 0.480 |
Why?
|
| Burns | 1 | 2017 | 101 | 0.470 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1159 | 0.460 |
Why?
|
| Tensile Strength | 9 | 2018 | 60 | 0.450 |
Why?
|
| Kidney Diseases | 1 | 2018 | 242 | 0.450 |
Why?
|
| Osteoblasts | 2 | 2006 | 43 | 0.440 |
Why?
|
| RNA | 1 | 2015 | 94 | 0.440 |
Why?
|
| Heparin | 2 | 2012 | 65 | 0.440 |
Why?
|
| Cells, Immobilized | 2 | 2014 | 22 | 0.430 |
Why?
|
| Rabbits | 7 | 2019 | 214 | 0.420 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 7 | 0.420 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 108 | 0.420 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 47 | 0.420 |
Why?
|
| Chondrocytes | 5 | 2018 | 70 | 0.410 |
Why?
|
| Obesity | 1 | 2021 | 1108 | 0.410 |
Why?
|
| Cell Culture Techniques | 7 | 2016 | 167 | 0.400 |
Why?
|
| Female | 13 | 2025 | 19954 | 0.380 |
Why?
|
| Fibrin | 1 | 2013 | 33 | 0.380 |
Why?
|
| Trachea | 3 | 2019 | 53 | 0.380 |
Why?
|
| Rheology | 5 | 2019 | 35 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 8 | 0.370 |
Why?
|
| Male | 18 | 2021 | 19434 | 0.360 |
Why?
|
| Muramidase | 1 | 2012 | 9 | 0.360 |
Why?
|
| Time Factors | 6 | 2021 | 2196 | 0.360 |
Why?
|
| Proteins | 1 | 2013 | 147 | 0.350 |
Why?
|
| Substance P | 1 | 2011 | 22 | 0.350 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 27 | 0.340 |
Why?
|
| Nanostructures | 2 | 2008 | 20 | 0.330 |
Why?
|
| Muscle Development | 3 | 2019 | 52 | 0.330 |
Why?
|
| Porosity | 7 | 2025 | 39 | 0.320 |
Why?
|
| Chondrogenesis | 2 | 2025 | 19 | 0.310 |
Why?
|
| Endothelial Cells | 5 | 2014 | 190 | 0.310 |
Why?
|
| Skin | 2 | 2023 | 214 | 0.310 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2019 | 162 | 0.300 |
Why?
|
| Absorbable Implants | 2 | 2013 | 24 | 0.300 |
Why?
|
| Polyglycolic Acid | 5 | 2013 | 32 | 0.290 |
Why?
|
| Neurites | 2 | 2013 | 10 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 2 | 2024 | 114 | 0.290 |
Why?
|
| Transplantation | 1 | 2008 | 12 | 0.280 |
Why?
|
| Cattle | 6 | 2015 | 118 | 0.270 |
Why?
|
| Feasibility Studies | 2 | 2020 | 309 | 0.260 |
Why?
|
| Glycolates | 2 | 2005 | 7 | 0.260 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 34 | 0.260 |
Why?
|
| Spheroids, Cellular | 2 | 2025 | 35 | 0.260 |
Why?
|
| Cell Line | 9 | 2019 | 443 | 0.260 |
Why?
|
| Intestine, Small | 2 | 2006 | 44 | 0.260 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 75 | 0.250 |
Why?
|
| Polycarboxylate Cement | 2 | 2004 | 2 | 0.250 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 726 | 0.250 |
Why?
|
| Surface Properties | 6 | 2010 | 36 | 0.250 |
Why?
|
| Ear Auricle | 2 | 2018 | 5 | 0.240 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1073 | 0.240 |
Why?
|
| Antigens, CD | 2 | 2018 | 93 | 0.240 |
Why?
|
| Neuromuscular Junction | 2 | 2020 | 70 | 0.240 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 293 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 100 | 0.230 |
Why?
|
| Silicon Dioxide | 1 | 2025 | 8 | 0.230 |
Why?
|
| Drug Carriers | 1 | 2025 | 22 | 0.230 |
Why?
|
| Nanoparticles | 1 | 2025 | 50 | 0.220 |
Why?
|
| Finite Element Analysis | 1 | 2025 | 85 | 0.210 |
Why?
|
| Bone Substitutes | 1 | 2004 | 9 | 0.210 |
Why?
|
| Cross-Linking Reagents | 3 | 2014 | 18 | 0.210 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 544 | 0.200 |
Why?
|
| Oxygen | 4 | 2022 | 134 | 0.190 |
Why?
|
| Polyethylene | 1 | 2003 | 6 | 0.190 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2023 | 46 | 0.190 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 73 | 0.190 |
Why?
|
| Sheep | 4 | 2017 | 194 | 0.190 |
Why?
|
| Nerve Regeneration | 2 | 2013 | 47 | 0.180 |
Why?
|
| Collagen Type I | 3 | 2013 | 44 | 0.180 |
Why?
|
| Tendons | 2 | 2013 | 49 | 0.180 |
Why?
|
| Chlorates | 1 | 2002 | 1 | 0.180 |
Why?
|
| Aged | 5 | 2021 | 10257 | 0.170 |
Why?
|
| Viscosity | 2 | 2018 | 25 | 0.170 |
Why?
|
| Elasticity | 2 | 2018 | 41 | 0.170 |
Why?
|
| Kinetics | 3 | 2022 | 248 | 0.170 |
Why?
|
| Pregnancy | 3 | 2020 | 963 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 595 | 0.160 |
Why?
|
| Middle Aged | 5 | 2021 | 11843 | 0.160 |
Why?
|
| Republic of Korea | 1 | 2020 | 12 | 0.160 |
Why?
|
| Rats, Inbred Lew | 3 | 2015 | 123 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 58 | 0.160 |
Why?
|
| Delayed-Action Preparations | 2 | 2012 | 33 | 0.160 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 15 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2020 | 75 | 0.150 |
Why?
|
| Bioreactors | 3 | 2024 | 58 | 0.150 |
Why?
|
| Registries | 1 | 2021 | 294 | 0.150 |
Why?
|
| Injections | 2 | 2025 | 72 | 0.150 |
Why?
|
| Acute Disease | 1 | 2020 | 253 | 0.150 |
Why?
|
| Risk | 1 | 2020 | 305 | 0.150 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 98 | 0.150 |
Why?
|
| ROC Curve | 1 | 2019 | 169 | 0.150 |
Why?
|
| Fibroblasts | 4 | 2020 | 118 | 0.150 |
Why?
|
| Mandibular Prosthesis | 1 | 2019 | 2 | 0.150 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 9 | 0.150 |
Why?
|
| Methacrylates | 1 | 2019 | 3 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 101 | 0.140 |
Why?
|
| Algorithms | 1 | 2022 | 537 | 0.140 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 48 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 776 | 0.140 |
Why?
|
| Thrombin | 2 | 2010 | 25 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2020 | 411 | 0.140 |
Why?
|
| Nerve Net | 1 | 2020 | 137 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 563 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2019 | 455 | 0.140 |
Why?
|
| Graft Survival | 2 | 2017 | 292 | 0.140 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2018 | 191 | 0.140 |
Why?
|
| Fibroins | 1 | 2018 | 5 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 84 | 0.140 |
Why?
|
| Myoblasts | 2 | 2015 | 41 | 0.130 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 59 | 0.130 |
Why?
|
| Cytokines | 1 | 2019 | 236 | 0.130 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 89 | 0.130 |
Why?
|
| Tissue Expansion Devices | 1 | 2017 | 12 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 183 | 0.130 |
Why?
|
| Cicatrix | 1 | 2017 | 39 | 0.130 |
Why?
|
| Bioartificial Organs | 2 | 2015 | 26 | 0.130 |
Why?
|
| Myocardium | 1 | 2018 | 184 | 0.120 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 61 | 0.120 |
Why?
|
| Polyurethanes | 1 | 2016 | 5 | 0.120 |
Why?
|
| NIH 3T3 Cells | 4 | 2011 | 41 | 0.120 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 36 | 0.120 |
Why?
|
| Rats, Nude | 4 | 2020 | 48 | 0.120 |
Why?
|
| Mice, Nude | 5 | 2020 | 285 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3410 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1244 | 0.120 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2013 | 10 | 0.120 |
Why?
|
| Sus scrofa | 2 | 2015 | 47 | 0.120 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 444 | 0.120 |
Why?
|
| Myostatin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2015 | 9 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 896 | 0.120 |
Why?
|
| Cell Movement | 3 | 2019 | 165 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 77 | 0.110 |
Why?
|
| Pulmonary Valve | 1 | 2015 | 12 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2021 | 1424 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 466 | 0.110 |
Why?
|
| Prognosis | 1 | 2019 | 1529 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 34 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3612 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 110 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 74 | 0.110 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 58 | 0.110 |
Why?
|
| Adipogenesis | 2 | 2020 | 30 | 0.110 |
Why?
|
| Peptides | 1 | 2015 | 128 | 0.110 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 10 | 0.110 |
Why?
|
| Gene Expression | 1 | 2015 | 345 | 0.110 |
Why?
|
| Cell Division | 3 | 2004 | 91 | 0.100 |
Why?
|
| Cytoskeleton | 2 | 2013 | 20 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2014 | 131 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 246 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2015 | 181 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 3896 | 0.100 |
Why?
|
| Elastic Modulus | 3 | 2019 | 29 | 0.100 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 13 | 0.100 |
Why?
|
| Risk Factors | 1 | 2021 | 3938 | 0.100 |
Why?
|
| Poloxamer | 1 | 2013 | 4 | 0.100 |
Why?
|
| Myoglobin | 1 | 2013 | 11 | 0.100 |
Why?
|
| Carbocyanines | 1 | 2013 | 6 | 0.100 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 11 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 18 | 0.100 |
Why?
|
| Transplants | 1 | 2013 | 22 | 0.100 |
Why?
|
| Receptors, Cholinergic | 1 | 2013 | 26 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 27 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 52 | 0.090 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 4 | 0.090 |
Why?
|
| Equipment Design | 2 | 2017 | 177 | 0.090 |
Why?
|
| 3T3 Cells | 3 | 2002 | 11 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2019 | 554 | 0.090 |
Why?
|
| Culture Media | 1 | 2012 | 47 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 153 | 0.090 |
Why?
|
| Amines | 1 | 2012 | 23 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 93 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2012 | 64 | 0.090 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 29 | 0.090 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 60 | 0.090 |
Why?
|
| Heart Valves | 1 | 2011 | 16 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 24 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2013 | 236 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 54 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 35 | 0.090 |
Why?
|
| Water | 2 | 2004 | 65 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 470 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 184 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1211 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2010 | 66 | 0.080 |
Why?
|
| Infrared Rays | 2 | 2025 | 16 | 0.080 |
Why?
|
| Hardness | 2 | 2015 | 5 | 0.080 |
Why?
|
| Urinary Bladder | 2 | 2013 | 320 | 0.080 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 26 | 0.080 |
Why?
|
| Foreskin | 1 | 2009 | 8 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 42 | 0.070 |
Why?
|
| Elastin | 2 | 2006 | 16 | 0.070 |
Why?
|
| Cell Count | 1 | 2008 | 50 | 0.070 |
Why?
|
| Compressive Strength | 2 | 2019 | 20 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2017 | 38 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 177 | 0.060 |
Why?
|
| Hemostatics | 1 | 2006 | 13 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 31 | 0.060 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 42 | 0.060 |
Why?
|
| Lung | 1 | 2017 | 264 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 51 | 0.060 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 36 | 0.060 |
Why?
|
| Methotrexate | 1 | 2025 | 70 | 0.060 |
Why?
|
| Liver | 1 | 2017 | 491 | 0.050 |
Why?
|
| Cell Size | 1 | 2004 | 40 | 0.050 |
Why?
|
| Absorption | 1 | 2004 | 16 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 619 | 0.050 |
Why?
|
| Cell Separation | 2 | 2015 | 86 | 0.050 |
Why?
|
| Epidermis | 1 | 2023 | 29 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 93 | 0.050 |
Why?
|
| Wettability | 1 | 2003 | 2 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 6 | 0.050 |
Why?
|
| Electrodes | 1 | 2003 | 20 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 38 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 107 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 6 | 0.050 |
Why?
|
| Carbonates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 15 | 0.050 |
Why?
|
| Starch | 2 | 2012 | 8 | 0.050 |
Why?
|
| Biomedical Engineering | 2 | 2013 | 28 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2012 | 41 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 31 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2002 | 4 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2002 | 33 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 359 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 30 | 0.040 |
Why?
|
| Calcium | 2 | 2013 | 337 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 95 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 238 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 64 | 0.040 |
Why?
|
| Podocytes | 1 | 2019 | 19 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 22 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 126 | 0.040 |
Why?
|
| Osteocytes | 1 | 2019 | 4 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2019 | 5 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 8 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 115 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 45 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 107 | 0.040 |
Why?
|
| Esthetics | 1 | 2018 | 10 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 73 | 0.030 |
Why?
|
| Light | 1 | 2018 | 34 | 0.030 |
Why?
|
| Meiosis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Progesterone | 1 | 2016 | 78 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 150 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2016 | 54 | 0.030 |
Why?
|
| Oocytes | 1 | 2016 | 45 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 139 | 0.030 |
Why?
|
| Mandible | 1 | 2016 | 39 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 13 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 39 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 38 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 63 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 43 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 95 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 75 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 17 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 69 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 68 | 0.030 |
Why?
|
| Tenascin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 9 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 80 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 2013 | 35 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 40 | 0.020 |
Why?
|
| Sulfonic Acids | 1 | 2013 | 2 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 7 | 0.020 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 2013 | 1 | 0.020 |
Why?
|
| Collagenases | 1 | 2013 | 9 | 0.020 |
Why?
|
| Agrin | 1 | 2013 | 9 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2013 | 64 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 367 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 20 | 0.020 |
Why?
|
| Muscle Denervation | 1 | 2013 | 29 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2013 | 27 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 64 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2013 | 69 | 0.020 |
Why?
|
| Peroneal Nerve | 1 | 2012 | 13 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.020 |
Why?
|
| Axons | 1 | 2012 | 35 | 0.020 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 6 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 38 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 79 | 0.020 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2012 | 3 | 0.020 |
Why?
|
| Anthraquinones | 1 | 2012 | 5 | 0.020 |
Why?
|
| Aggrecans | 1 | 2012 | 4 | 0.020 |
Why?
|
| Collagen Type II | 1 | 2012 | 8 | 0.020 |
Why?
|
| Sepharose | 1 | 2012 | 6 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 132 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 62 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 73 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 478 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 9 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 21 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 9263 | 0.020 |
Why?
|
| Stifle | 1 | 2006 | 2 | 0.010 |
Why?
|
| Biological Dressings | 1 | 2006 | 1 | 0.010 |
Why?
|
| Occlusive Dressings | 1 | 2006 | 10 | 0.010 |
Why?
|
| Bandages | 1 | 2006 | 34 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 9 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 709 | 0.010 |
Why?
|
| Carbon | 1 | 1999 | 13 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 255 | 0.010 |
Why?
|